US20230132683A1 - Distributed flow path insufflation - Google Patents
Distributed flow path insufflation Download PDFInfo
- Publication number
- US20230132683A1 US20230132683A1 US18/148,590 US202218148590A US2023132683A1 US 20230132683 A1 US20230132683 A1 US 20230132683A1 US 202218148590 A US202218148590 A US 202218148590A US 2023132683 A1 US2023132683 A1 US 2023132683A1
- Authority
- US
- United States
- Prior art keywords
- channel
- flow path
- insufflation
- insufflation fluid
- bypass valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012530 fluid Substances 0.000 claims abstract description 64
- 238000000034 method Methods 0.000 claims description 50
- 238000009530 blood pressure measurement Methods 0.000 claims description 34
- 230000004044 response Effects 0.000 claims description 13
- 230000008878 coupling Effects 0.000 claims description 8
- 238000010168 coupling process Methods 0.000 claims description 8
- 238000005859 coupling reaction Methods 0.000 claims description 8
- 238000005259 measurement Methods 0.000 description 13
- 230000008901 benefit Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 4
- 230000004075 alteration Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001143 conditioned effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000012976 endoscopic surgical procedure Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
- A61M13/003—Blowing gases other than for carrying powders, e.g. for inflating, dilating or rinsing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3474—Insufflating needles, e.g. Veress needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/16—Devices to humidify the respiration air
- A61M16/161—Devices to humidify the respiration air with means for measuring the humidity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/16—General characteristics of the apparatus with back-up system in case of failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3344—Measuring or controlling pressure at the body treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1021—Abdominal cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
- A61M39/223—Multiway valves
Definitions
- the present invention disclosure relates generally to medical procedures and more particularly to a method and system for insufflating a patient cavity using a distributed flow path.
- insufflation Providing an insufflation gas into a body cavity is referred to as insufflation.
- the purpose of insufflation is to inflate or distend the body cavity to allow a surgeon to explore a surgical site and/or otherwise provide a view of the site to be treated or observed.
- Insufflation is used in many common procedures including endoscopic surgical procedures, laparoscopic procedures performed on the abdominal cavity and orthoscopic procedures performed on the chest cavity.
- Additional medical access devices e.g., trocars
- trocars can be used during the same surgical procedure to remove surgical smoke from the patient cavity or to continuously measure pressure within the body cavity.
- insufflation gas is typically treated before being delivered to a patient cavity.
- an insufflation gas is heated and hydrated (i.e., conditioned) before being directed, in some cases, by a trocar into a patient cavity.
- a charge of hydration fluid is typically injected into a device where the hydration fluid can humidify the insufflation gas and a heater can bring the insufflation gas to a temperature near body temperature.
- the conditioned insufflation gas is then delivered to a medical appliance (e.g., a trocar) for injection into a body cavity of a patient.
- a medical appliance e.g., a trocar
- a system includes a bypass valve, a first conduit, and a second conduit.
- the bypass valve includes at least a first channel and a second channel, the first channel defining a portion of a first flow path for insufflation fluid and the second channel defining a first portion of a second flow path for the insufflation fluid.
- the bypass valve is configured to permit the insufflation fluid to flow along the first flow path when the second channel is closed and permit the insufflation fluid to flow along the second flow path when the first channel is closed.
- the first conduit is coupled to the bypass valve and is configured to facilitate delivery of the insufflation fluid from an insufflator to the bypass valve.
- the second conduit is coupled to the first channel of the bypass valve and is configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a first medical appliance.
- a method for insufflating a body cavity with insufflation fluid includes determining, by an insufflator, a first pressure measurement indicative of a pressure of a patient cavity and supplying, by the insufflator, the insufflation fluid to the patient cavity based on the first pressure measurement, wherein the insufflation fluid is supplied according to a first setting which comprises at least a first volume and a first pressure.
- Supplying the insufflation fluid to the patient cavity includes directing the insufflation fluid through a first conduit to a bypass valve, the bypass valve including at least a first channel and a second channel defining a portion of a first flow path and first portion of a second flow path, respectively.
- Supplying the insufflation fluid to the patient cavity further includes directing the insufflation fluid to the patient cavity via the first flow path when the second channel is closed, wherein the first flow path is further defined by a second conduit coupling the first channel of the bypass valve to a first medical appliance, and directing the insufflation fluid to the patient cavity via the second flow path when the first channel is closed, wherein the second flow path is further defined by a second conduit coupling the second channel of the bypass valve to a second medical appliance
- a system includes an insufflator, a bypass valve, a first conduit, a second conduit, and a third conduit.
- the bypass valve includes at least a first channel and a second channel, the first channel defining a portion of a first flow path for the insufflation fluid and the second channel defining a portion of a second flow path for the insufflation fluid, wherein: the bypass valve is configured to permit the insufflation fluid to flow along the first flow path when the second channel is closed; and the bypass valve is configured to permit the insufflation fluid to flow along the second flow path when the first channel is closed.
- the first conduit is coupled to the bypass valve and configured to facilitate delivery of the insufflation fluid from the insufflator to the bypass valve.
- the second conduit is coupled to the first channel of the bypass valve and is configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a first medical appliance.
- the third conduit is coupled to the second channel of the bypass valve and is configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a second medical appliance.
- a method allows for the continuous monitoring of pressure associated with a patient cavity during and after insufflation of the patient cavity. Continuous monitoring may result in decreased potential for physician harm resulting from insufflation fluid leakage and thus may also result in an increase in physician confidence while performing surgical procedures.
- a method provides for intelligent pressure monitoring wherein pressure sensors are automatically disabled when not in use. Thus, the intelligent pressure monitoring feature is associated with a reduction in power and computing resources.
- a method provides for the elimination of duplicate insufflation components (e.g., insufflator and conduits connecting to insufflation delivery device such as an insufflation needle or trocar).
- duplicate insufflation components e.g., insufflator and conduits connecting to insufflation delivery device such as an insufflation needle or trocar.
- FIG. 1 illustrates an example of an insufflation system comprising an insufflator, a trocar, an insufflation needle, and a valve, according to certain embodiments of the present invention
- FIG. 2 illustrates the valve of the system of FIG. 1 , according to certain embodiments of the present invention
- FIG. 3 is a flow chart illustrating a method of insufflating a patient cavity using the valve of FIG. 2 , according to one embodiment of the present invention
- FIG. 4 illustrates an example controller operable to control one or more components of system 100 , including the insufflator of FIG. 1 .
- insufflation gas One of the requirements for delivery of insufflation gas to a patient's body cavity is to maintain the proper flow of insufflation gas into the body cavity.
- gas flows from a high-pressure gas source, which is remote from the patient, through an insufflation device and finally into a trocar where the gas is injected into the patient's body cavity.
- the insufflation gas is stored in high-pressure containers and a pressure regulator reduces the pressure of the gas to a lower pressure.
- the low pressure gas is typically delivered to the trocar through an insufflation device containing a set of inline end connectors that couple the source of insufflation gas, the pressure regulator, the filter, the heater, the hydrator, and the trocar to each other.
- the insufflation gas is conditioned by filtering, heating and/or hydrating.
- the insufflation gas may flow through any suitable number of inline end connectors, which are typically connected by flexible tubing (also referred to herein as conduits), before being delivered to the patient cavity.
- physicians or other medical practitioners may prefer to deliver insufflation gas to patient cavity in two phases, first using a first medical appliance (e.g., an insufflation needle) and thereafter using second medical appliance (e.g., a trocar). Delivering insufflation gas via two different medical appliances may be preferred because one medical appliance may have a smaller profile than the other.
- a first medical appliance e.g., an insufflation needle
- second medical appliance e.g., a trocar
- one conventional solution requires two sets of insufflation components (e.g., insufflator, conduits); one set to be used with the first medical appliance and the other set to be used with the second medical appliance.
- insufflation components e.g., insufflator, conduits
- the '132 patent generally describes a two-stage insufflation method using a trocar-adaptor-needle assembly (i.e., coupling, using an adaptor, a trocar cannula to an insufflation needle). At the first stage of the insufflation method, insufflation fluid is delivered through the trocar-adaptor-needle assembly; at the second stage of the insufflation method, insufflation fluid is delivered directly through the trocar cannula.
- Transition from the first stage of the insufflation method to the second stage of the insufflation method requires disconnection of the adaptor and needle from the trocar-adaptor-needle assembly.
- adaptor eliminates the need for duplicative insufflation components, such delivery method is not a perfect solution.
- disconnection of the adaptor and needle from trocar-adaptor-needle assembly requires the removal of the trocar-adaptor-needle from the patient cavity. In the period of time that it takes to remove the trocar-adaptor-needle assembly, modify the trocar-adaptor-needle assembly, and thereafter position and insert the trocar in the patient cavity, leakage of the insufflation fluid may occur.
- any leakage of the insufflation fluid results in deflation of the patient cavity and therefore diminishes the physician's view of the site of interest.
- inserting a trocar into a patient cavity that is not sufficiently inflated is risky as the trocar may pierce or otherwise damage organs surrounding the site of interest.
- a popular two-phase insufflation solution involves initially insufflating using a first medical appliance (e.g., an insufflation needle) connected to a conduit, that is in turn connected to the insufflator. Once the patient cavity is sufficiently insufflated using the first medical appliance, the conduit is disconnected from the first medical appliance and connected to a second medical appliance (e.g., a trocar).
- a second medical appliance e.g., a trocar
- the present disclosure describes an insufflation system and method that overcomes the shortcomings of the conventional insufflation solutions described above.
- the present disclosure describes an insufflation system and method that operates using a single set of insufflation components and reduces or eliminates leakage of insufflation gas during the insufflation process, in one embodiment.
- the insufflation system and method described herein also contemplates intelligent pressure monitoring which provides various efficiencies with respect to time and computing resources. Example embodiments are best understood by referring to FIGS. 1 through 4 of the drawings and the description below, like numerals being used for like and corresponding parts of the various drawings.
- FIG. 1 is a schematic diagram of an insufflation system 100 .
- insufflation system 100 includes an insufflator 110 , conduits 160 , a valve 120 , and one or more medical appliances.
- insufflation system 100 includes a first medical appliance (i.e., insufflation needle 130 ) and a second medical appliance (i.e., trocar 140 ).
- Other embodiments of insufflation system 100 may include other medical appliances.
- both the first and second medical appliances are trocars, the first medical appliance being a hasson trocar.
- system 100 may include one or more additional components.
- system 100 may further include a controller that controls the operation of one or more components of FIG. 1 . This disclosure describes and depicts an example of such controller with respect to FIG. 4 .
- FIG. 1 shows the distal end of insufflation needle 130 and trocar 140 positioned within the abdominal cavity 150 of a patient.
- insufflator 110 supplies insufflation gas to patient cavity 150 .
- the insufflation gas is directed from insufflator to valve 120 via conduit 160 a and is thereafter directed to patient cavity 150 via at least one flow path.
- FIG. 1 illustrates two flow paths: the first flow path, identified in FIG. 1 as “Flow Path A,” includes conduit 160 b and insufflation needle 130 ; the second flow path, identified in FIG. 1 as “Flow Path B,” includes conduit 160 c and trocar 140 .
- valve 120 is configured to direct the insufflation gas to at least one of Flow Path A or Flow Path B.
- trocar 140 permits the insertion of a surgical instrument (not illustrated) into patient cavity 150 .
- a physician or other medical practitioner can insert a surgical instrument through an inner tubular lumen 146 of trocar 140 in order to access patient cavity 150 with the surgical instrument.
- System 100 may further include one or more sensors 142 .
- Sensors 142 are configured to measure a variable (e.g., pressure, humidity, temperature) and are, in some embodiments, communicatively coupled to other components of system 100 (e.g., controller of system 100 , insufflator 110 ).
- Sensors 142 may be communicatively coupled to components of system 100 via a wired or wireless connection. As illustrated in FIG. 1 , sensors 142 a and 142 b communicate with insufflator 110 via cables 170 a and 170 b , respectively.
- Communications between sensors 142 and components of system 100 may include instructing sensor 142 to take a measurement, sensor 142 reporting a measurement, instructing insufflator 110 to supply insufflation gas under specified conditions (e.g., at a particular pressure and/or volume).
- system 100 includes three sensors: sensors 142 a , 142 b , and 142 c .
- Sensor 142 a may be configured to (1) measure a humidity and/or temperature of the insufflation gas as it flows through trocar 140 ; and (2) communicate such measurement(s) to insufflator 110 and/or a controller of insufflation system 100 .
- Sensors 142 b and 142 c may be configured to (1) measure a pressure corresponding to patient cavity 150 ; and (2) communicate such measurement to insufflator 110 and/or a controller of insufflation system 100 .
- sensor 142 b may measure a pressure corresponding to patient cavity 150 through an outer tubular lumen 144 of trocar 140 and sensor 14 b may measure a pressure corresponding to patient cavity 150 through Flow Path B.
- this disclosure describes and depicts only three sensors 142 , this disclosure contemplates system 100 including any appropriate number of sensors.
- Sensors 142 may sense pressure or a change in pressure. Sensor 142 may measure absolute pressure or a pressure relative to some other pressure. In some embodiments, sensor 142 is an absolute sensor that can measure pressure in patient cavity 150 (if disposed within patient cavity 150 ) or in the room in which the associated operation is taking place. In particular embodiments, sensor 142 can measure absolute barometric pressures with an accuracy of less than 1 Pascal pressure and therefore have the ability to measure the relative changes in altitude of close to one inch. Such pressure sensors are readily available in the marketplace. Insufflator 110 of system 100 may be any suitable source of insufflation gas at any suitable pressure and may include a pressurized gas source.
- Insufflator 110 may adjust the supply of insufflation gas to patient cavity 150 by adjusting the pressure and/or the volume of insufflation gas supplied to patient cavity 150 . As described above, insufflator 110 may supply insufflation gas to patient cavity 150 based on one or more pressure measurements (e.g., pressure measurements taken by sensors 142 b and/or 142 c ).
- the insufflation gas may be any suitable gas used for insufflation purposes. As one example, insufflation gas may be carbon dioxide.
- Insufflator 110 may include any appropriate hardware and/or software for processing signals indicative of insufflation gas measurements and processing such signals to convert them into useful information, such as converting them into pressures, heights, and/or other data that can be used control the flow of insufflation gas to patient cavity 150 , and further for processing such data to determine a desired pressure and/or volume of insufflation gas supplied to patient cavity 150 and for effecting such delivery.
- insufflator 110 may include at least one processor, a computer-readable medium to store instructions, and at least one communication interface for receiving and sending information.
- insufflator 110 includes a controller such as the controller 400 described and depicted in FIG. 4 .
- valve 120 may be any suitable device configured to direct insufflation gas along two or more flow paths. As illustrated in FIGS. 1 & 2 , valve 120 is configured to discharge insufflation gas to one of two flow paths: Flow Path A and Flow Path B. Insufflation gas carried via Flow Path A is discharged from valve 120 to conduit 160 b and is thereafter directed through a first medical appliance (e.g., insufflation needle 130 ) to patient cavity 150 . In contrast, insufflation gas carried via Flow Path B is discharged from valve 120 to conduit 160 c and is thereafter directed through a second medical appliance (e.g., trocar 140 ) to patient cavity 150 . Valve 120 is further described in reference to FIG. 2 .
- first medical appliance e.g., insufflation needle 130
- a second medical appliance e.g., trocar 140
- conduits 160 may direct the flow of insufflation gas between components of system 100 .
- conduits 160 couple to ports located on such components.
- conduit 160 a is coupled on one end to a port corresponding to insufflator 110 and is coupled on the opposite end to a port corresponding to valve 120 .
- conduit 160 b is coupled on one end to a port corresponding to valve 120 and is coupled on the opposite end to a port corresponding to insufflation needle 130 .
- conduit 160 c is coupled on one end to a port corresponding to valve 120 and is coupled on the opposite end to a port corresponding to trocar 140 .
- Conduits 160 may comprise any suitable material that facilitates the transport of insufflation gas.
- conduits 160 may comprise flexible PVC tubing.
- conduits 160 in addition to providing a pathway for transporting insufflation gas, conduits 160 provide a pathway for taking pressure measurements.
- sensor 142 c may take a pressure measurement indicative of a pressure of patient cavity 150 via conduits 160 a and 160 b .
- pressure measurements indicative of the pressure of body cavity 150 may be taken via Flow Path A when insufflator 110 is not supplying insufflation gas.
- system 100 is described and depicted as having only three conduits 160 , this disclosure contemplates system 100 including any suitable number of conduits 140 .
- system 100 includes trocar 140 .
- Trocar 140 may be any suitable trocar through which insufflation gas may be supplied to a patient cavity. Examples of one or more trocars are provided in U.S. Pat. No. 8,715,219 (the '219 patent), U.S. Pat. No. 7,285,112 (the '112 patent), and U.S. Pat. No. 8,216,189 (the '189 patent), which are hereby incorporated by reference as if fully set forth herein.
- Trocar 140 may have a single lumen or may be formed with an inner tubular lumen and an outer tubular lumen such that insufflation gas may be supplied through one of the lumens but not the other. Further, any of the lumens may be divided into multiple, separate chambers, such that gas in one chamber does not enter the other chamber. Examples of the above multiple lumens and multiple chambered trocars are described in U.S. application Ser. No. 14/792,873, entitled “Method and System for Gas Maintenance to a Body Cavity Using a Trocar,” which is hereby incorporated by reference. Trocar may be open or closed at the distal end, as the application of the trocar would allow.
- trocar 140 includes an outer tubular lumen 144 disposed about an inner tubular lumen 146 .
- Medical instruments e.g., scope, grasper, scissors
- inner tubular lumen 146 of trocar 140 may be inserted through inner tubular lumen 146 of trocar 140 in order to access the site of interest within body cavity 150 .
- outer tubular lumen 144 is divided into two or more chambers (e.g., chamber 144 a and chamber 144 b ).
- the division of outer tubular lumen 144 into separate chambers may provide benefits which will be recognized by one of ordinary skill in the art.
- trocar 140 can deliver insufflation gas to patient cavity 150 while also measuring a pressure (e.g., using sensor 142 ) indicative of a pressure of patient cavity 150 .
- conduit 160 c directs insufflation gas to chamber 144 a of trocar 140 where it is thereafter directed, via apertures 148 a , to patient cavity 150 .
- FIG. 1 conduit 160 c directs insufflation gas to chamber 144 a of trocar 140 where it is thereafter directed, via apertures 148 a , to patient cavity 150 .
- apertures 148 b provide a path into chamber 144 b of trocar 140 in which sensor 142 b may take a pressure measurement indicative of a pressure of patient cavity 150 .
- trocar 140 is depicted in FIG. 1 as having two apertures 148 a and two aperture 148 b , this disclosure recognizes that trocar 140 may include any suitable number of apertures 148 a and 148 b.
- trocar 140 may include any suitable number of sensors 142 , one or more of which may be capable of taking pressure measurements. Sensors 142 may be located anywhere in, on, or through trocar 140 . In some embodiments, sensors 142 are located on the exterior of trocar 140 such that changes of pressure within trocar 140 (e.g., due to the supply of insufflation gas to patient cavity 150 ) do not affect the pressure measured by sensor 142 . As described above, sensors 142 may be absolute pressure sensors that can measure pressure in patient cavity 150 (if disposed within patient cavity 150 ) or in the room in which the associated operation is taking place.
- Sensors 142 may be coupled to components of system 100 through any suitable technique, including a wireless or a wired connection (e.g., cables 170 a and 170 b ).
- Sensor 142 supplies pressure data to a controller of system 100 , which may be comprised within insufflator 110 .
- insufflator 110 uses this pressure data to control the supply on insufflation gas by insufflator 110 .
- this may include determining the change in height of trocar 140 relative to changes in cavity pressure and thus the resulting change in height of patient cavity 150 , as described in greater detail in co-pending application Ser. No. 15/293,013 entitled Method and System for Controlling Pressurization of a Patient Cavity Using Cavity Distension Measured by a Pressure Sensor of a Trocar incorporated herein by reference.
- system 100 is used to insufflate patient cavity 150 .
- insufflation may begin.
- insufflation needle 130 and trocar 140 are inserted into patient cavity 150 and valve 120 is opened such that insufflation gas can be delivered via Flow Path A.
- Insufflator 110 may then be turned on such that insufflation gas is delivered to patient cavity 150 via Flow Path A.
- one or more measurements are taken by sensors 142 and relayed to insufflator 110 as described above.
- insufflator 110 supplies insufflation gas to patient cavity 150 based on measurements taken by sensors 142 .
- valve 120 is adjusted to permit the flow of insufflation gas along Flow Path B such that insufflation gas is delivered to patient cavity 150 through trocar 140 .
- insufflation gas may be delivered along Flow Path A without first coupling conduit 160 c to trocar 140 .
- conduit 160 c is coupled to valve 120 and trocar 140 before valve 120 is adjusted to permit insufflation fluid to flow along Flow Path B.
- system 100 may be assembled during or after use of one or more components of system 100 .
- system 100 may be disassembled during or after use of one or more components of system 100 .
- conduit 160 b and insufflation needle 130 may be removed from system 100 .
- valve 120 in further detail with respect to FIG. 2 and describes certain methods of insufflating a patient cavity with respect to FIG. 3 .
- this disclosure describes details of a controller of system 100 with respect to FIG. 4 .
- FIG. 2 illustrates one embodiment of valve 120 .
- valve 120 is a ball valve that provides multiple flow paths.
- this disclosure describes and depicts valve 120 as a ball valve, this disclosure recognizes that valve 120 may be any suitable type of valve 120 that provides multiple flow paths for insufflation gas.
- this disclosure recognizes valve 120 being any suitable solenoid or pneumatic valve.
- valve 120 includes handle 210 , inlet 220 , a first outlet 230 , a second outlet 240 , and a ball 260 .
- ball 260 is rotated within valve 120 based on movements of handle 210 .
- One or more channels 250 within valve 120 may be opened as ball 260 rotates within valve 120 .
- turning handle 210 90° may open channel 250 a and close channel 250 b .
- insufflation gas may be permitted to flow into inlet 220 and out of valve 120 via outlet 230 .
- turning handle 210 180° may open channel 250 b and close channel 250 a .
- insufflation gas may be permitted to flow into inlet 220 and out of valve 120 via outlet 240 .
- turning handle 210 270° may close two or more channels 250 (e.g., 250 a and 250 b ) such that insufflation gas cannot flow along Flow Path A or Flow Path B (or insufflation gas is otherwise blocked from flowing into inlet 220 of valve 120 ).
- turning handle 210 360° may open two or more channels 250 (e.g., 250 a and 250 b ) such that insufflation gas is permitted to flow along Flow Path A and Flow Path B.
- conduit 160 a is coupled to inlet 220 to permit the flow of insufflation gas from insufflator 110 to valve 120 .
- conduit 160 b is coupled to outlet 230 to permit the flow of insufflation gas along Flow Path A
- conduit 160 c is coupled to outlet 240 to permit the flow of insufflation gas along Flow Path B. Accordingly, this disclosure recognizes that turning handle 210 may permit insufflation gas to flow along Flow Path A and/or Flow Path B.
- valve 120 does not include handle 210 to control actuation of ball 260 .
- ball 260 (or other suitable valve mechanism for blocking, or otherwise closing, channels 250 ) may actuate based on receipt of instructions from a controller (e.g., controller 400 of FIG. 4 ).
- controller may be comprised within insufflator 110 . In other embodiments, such controller may be external to insufflator 110 .
- controller is programmed to actuate ball 260 (or other suitable valve mechanism for blocking, or otherwise closing, channels 250 ) in a manner that closes one flow path (e.g., Flow Path A) and opens another flow path (e.g., Flow Path B) in response to determining that desired levels of insufflation gas have been attained (e.g., when patient cavity 150 has been insufflated to 15 mmHg).
- ball 260 or other suitable valve mechanism for blocking, or otherwise closing, channels 250
- Flow Path A closes one flow path
- Flow Path B another flow path
- insufflation gas may be continuously delivered to patient cavity 150 even though the flow path for the insufflation gas has changed.
- continuous flow of insufflation gas may result in certain benefits relative to conventional insufflation system, including reducing or eliminating leakage of insufflation gas.
- FIG. 3 is a flow chart illustrating a method 300 of insufflating a patient cavity using system 100 .
- the method may utilize structural items such as those described in FIGS. 1 through 2 or may use alternative structural items.
- Computational steps described below may be performed by any suitable computation device, including a controller that may or may not be a subcomponent of insufflator 110 .
- the method 300 begins at step 305 and continues to step 310 .
- system 100 measures a pressure indicative of a pressure of patient cavity 150 .
- the pressure measurement taken at step 310 is measured by one or more sensors 142 .
- sensors 142 may be located in, on, or through trocar 140 and/or insufflator 110 .
- sensors 142 may continuously measure a pressure within patient cavity 150 and communicate a signal indicative of the measurement(s) to the controller of system 100 .
- one or more pressure measurements are taken by sensor 142 b and communicated to a controller (e.g., controller 400 of FIG. 4 .
- gas may enter into outer chamber 144 b of trocar 140 through apertures 148 b so that the pressure of the gas may be measured by sensor 142 b .
- one or more pressure measurements are taken by sensor 142 c collocated with insufflator 110 .
- pressure measurements using sensor 142 c should occur when insufflator 110 is not supplying insufflation gas to patient cavity 150 .
- sensors 142 may be located in any suitable position that would permit sensors 142 to measure pressure indicative of a pressure of patient cavity 150 . Once system 100 determines such pressure measurement(s), the method 300 may proceed to step 320 .
- system 100 supplies insufflation gas to patient cavity 150 based on the pressure measurement taken at step 310 .
- controller may instruct insufflator 110 to supply 1 L/min of insufflation gas to patient cavity.
- sensor 142 a may be configured to sense humidity and/or temperature information which is relayed to a controller that thereafter instructs insufflator 110 to adjust the humidity and/or temperature of the supply of insufflation gas.
- system 100 determines whether first channel 250 a is open (not blocked) or closed (blocked). If at step 350 , system 100 determines that first channel 250 a is open, the method 300 proceeds to a step 340 a . If at step 250 , system 100 instead determines that first channel 250 a is closed, the method 300 proceeds to a step 340 b.
- system 100 directs the insufflation gas to a first flow path (e.g., Flow Path A of FIG. 1 ).
- system 100 directs the insufflation gas to a second flow path (e.g., Flow Path B of FIG. 1 ).
- a first flow path e.g., Flow Path A of FIG. 1
- a second flow path e.g., Flow Path B of FIG. 1
- channels 250 of valve 120 may be opened or closed manually (e.g., by turning handle 210 ) and/or based on instructions provided by the controller of system 100 (e.g., controller 400 ).
- channel 250 a should be opened and channel 250 b should be closed.
- insufflator 110 may discharge insufflation gas to valve 120 via conduit 160 a and can thereafter be directed to insufflation needle 130 via conduit 160 b (Flow Path A).
- the method 300 proceeds to an end step 345 once insufflation gas has been directed to either the first or second flow path.
- the method 300 may continue to a step whereby it is determined that patient cavity 150 is insufflated to a desired level (15 mmHg). Upon determining that the desired level has been reached, channel 250 a may be closed and channel 250 b may be opened such that insufflation gas can be delivered along Flow Path B (rather than Flow Path A). In some embodiments, this transition may be performed automatically. For example, upon determining that patient cavity has a pressure of 15 mmHg, controller may instruct ball 260 (or other suitable valve mechanism for blocking, or otherwise closing, channels 250 ) to rotate such that channel 250 a is closed and channel 250 b is open.
- controller may instruct ball 260 (or other suitable valve mechanism for blocking, or otherwise closing, channels 250 ) to rotate such that channel 250 a is closed and channel 250 b is open.
- system 100 may also be configured to implement certain functionalities in response to determining that one or more channels 250 of valve 120 are closed.
- system 100 may automatically adjust the operational settings of insufflator 110 in response to determining that one channel 250 has been opened and another channel 250 has been closed.
- insufflator may receive instructions to adjust the volume and/or pressure of the insufflation gas being supplied in order to ensure that the pressure of patient cavity 150 is maintained in response to a controller of system 100 determining that channel 250 a is closed.
- system 100 may automatically disable one or more sensors 142 from taking measurements (e.g., pressure measurements) in response to determining that one channel 250 has been opened and another channel 250 has been closed.
- insufflator 110 may display, on insufflator 110 , a message indicating such (e.g., insufflator 110 may display “OCCLUSION” or “ERROR”)
- adjusting operational settings of system components may result in efficiency and/or timing benefits.
- controller of system 100 determines that one or more channels 250 are closed based on a rapid pressure rate rise/decline. For example, controller may determine that channel 250 a and/or 250 b is closed by determining that the pressure within patient cavity 150 increased or decreased by 5 mmHG within 1 seconds.
- controller may determine that channel 250 a and/or 250 b is closed by determining that the pressure within patient cavity 150 increased or decreased by 5 mmHG within 1 seconds.
- Method 300 may also include one or more of the following steps: (1) determine that a first sensor 142 is providing inaccurate or unreliable pressure readings; and (2) to instruct insufflator 110 to supply insufflation gas based on measurements determined by a second sensor 142 .
- controller of system 100 is responsible for performing these steps.
- controller of system 100 analyzes pressure measurement(s) received from a first sensor 142 for indications of whether the signals are indicative of the measured pressure being inaccurate or otherwise suggesting that first sensor 142 is operating in a less than optimal manner.
- any suitable factors may be considered in such analysis; however, certain factors that may indicate first sensor 142 is operating in a less than optimal manner include (1) whether the received signal is not within an expected range for the received signal; (2) whether error data is received, such as whether errors have occurred due to interference from a power signal, the wrong number of bits have been received, data is received in the wrong format, or data is received with improper spacing (3) whether proper acknowledgment bits are not received from the primary pressure sensor, (4) whether the received signal is not within an expected voltage range, (5) whether expected new updated status bits are not received, such as whether a signal has changed enough to indicate a new measurement has occurred as opposed to a signal being so close to a previous signal to indicate no new measurement has occurred; and (6) in the case where system 100 includes two or more pressure sensors 142 , whether measurements by the two or more sensors 142 are not within a certain range of each other.
- controller of system 100 may instruct insufflator 110 to supply insufflation gas based on pressure readings from a second sensor 142 .
- first sensor 142 is disabled upon determining that first sensor 142 is providing inaccurate or unreliable pressure readings.
- pressure readings from first sensor 142 are ignored upon determining that first sensor 142 is providing inaccurate or unreliable pressure readings.
- the method 300 may also include one or more disassembly steps wherein components may be removed from system 100 (e.g., insufflation needle 130 and/or conduit 160 b ) although insufflation gas continues to be delivered to patient cavity 150 (e.g., via conduit 160 c and trocar 140 ).
- components may be removed from system 100 (e.g., insufflation needle 130 and/or conduit 160 b ) although insufflation gas continues to be delivered to patient cavity 150 (e.g., via conduit 160 c and trocar 140 ).
- sensors 142 have been described above as being located on trocar 140 and/or insufflator 110 , sensor 142 may also be located on, in, or through other medical appliances as well.
- Such medical appliances may be or include one of: a needle, a stapler, a grasper, a pair of scissors, a scalpel, a cutter, an electrode, an end seal, a probe, a multiple access port, and a single access port.
- this disclosure identifies certain types of medical appliances (including trocars 140 ), this disclosure recognizes that sensor 142 may be located on, in, or through any suitable medical appliance. For example, this disclosure recognizes any medical appliance that can puncture the skin as a medical appliance.
- FIG. 4 illustrates an example controller 400 of system 100 , according to certain embodiments of the present invention.
- controller may be internal or external to one or more components of system 100 .
- controller is comprised within insufflator 110 .
- Controller 400 may comprise one or more interfaces 410 , memory 420 , and one or more processors 430 .
- Interface 410 receives input (e.g., sensor data, user input), sends output (e.g., instructions), processes the input and/or output, and/or performs other suitable operation.
- Interface 410 may comprise hardware and/or software.
- Processor 430 may include any suitable combination of hardware and software implemented in one or more modules to execute instructions and manipulate data to perform some or all of the described functions of controller 400 .
- processor 430 may include, for example, one or more computers, one or more central processing units (CPUs), one or more microprocessors, one or more applications, one or more application specific integrated circuits (ASICs), one or more field programmable gate arrays (FPGAs), and/or other logic.
- CPUs central processing units
- microprocessors one or more applications
- ASICs application specific integrated circuits
- FPGAs field programmable gate arrays
- Memory (or memory unit) 420 stores information.
- Memory 420 may comprise one or more non-transitory, tangible, computer-readable, and/or computer-executable storage media.
- Examples of memory 420 include computer memory (for example, Random Access Memory (RAM) or Read Only Memory (ROM)), mass storage media (for example, a hard disk), removable storage media (for example, a Compact Disk (CD) or a Digital Video Disk (DVD)), database and/or network storage (for example, a server), and/or other computer-readable medium.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgical Instruments (AREA)
Abstract
A system includes a bypass valve, a first conduit, and a second conduit. The bypass valve includes at least a first channel and a second channel and is configured to permit insufflation fluid to flow along a first flow path when the second channel is closed and permit the insufflation fluid to flow along a second flow path when the first channel is closed. The first conduit is coupled to the bypass valve and is configured to facilitate delivery of the insufflation fluid from an insufflator to the bypass valve. The second conduit is coupled to the first channel of the bypass valve and configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a first medical appliance.
Description
- The present invention disclosure relates generally to medical procedures and more particularly to a method and system for insufflating a patient cavity using a distributed flow path.
- Providing an insufflation gas into a body cavity is referred to as insufflation. The purpose of insufflation is to inflate or distend the body cavity to allow a surgeon to explore a surgical site and/or otherwise provide a view of the site to be treated or observed. Insufflation is used in many common procedures including endoscopic surgical procedures, laparoscopic procedures performed on the abdominal cavity and orthoscopic procedures performed on the chest cavity. Additional medical access devices (e.g., trocars) can be used during the same surgical procedure to remove surgical smoke from the patient cavity or to continuously measure pressure within the body cavity.
- As described in U.S. Pat. Nos. 5,411,474, 6,068,609, and 7,066,902 (incorporated by reference herein), insufflation gas is typically treated before being delivered to a patient cavity. Briefly, an insufflation gas is heated and hydrated (i.e., conditioned) before being directed, in some cases, by a trocar into a patient cavity. In order to hydrate the insufflation gas a charge of hydration fluid is typically injected into a device where the hydration fluid can humidify the insufflation gas and a heater can bring the insufflation gas to a temperature near body temperature. The conditioned insufflation gas is then delivered to a medical appliance (e.g., a trocar) for injection into a body cavity of a patient.
- According to one embodiment, a system includes a bypass valve, a first conduit, and a second conduit. The bypass valve includes at least a first channel and a second channel, the first channel defining a portion of a first flow path for insufflation fluid and the second channel defining a first portion of a second flow path for the insufflation fluid. The bypass valve is configured to permit the insufflation fluid to flow along the first flow path when the second channel is closed and permit the insufflation fluid to flow along the second flow path when the first channel is closed. The first conduit is coupled to the bypass valve and is configured to facilitate delivery of the insufflation fluid from an insufflator to the bypass valve. The second conduit is coupled to the first channel of the bypass valve and is configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a first medical appliance.
- According to another embodiment, a method for insufflating a body cavity with insufflation fluid includes determining, by an insufflator, a first pressure measurement indicative of a pressure of a patient cavity and supplying, by the insufflator, the insufflation fluid to the patient cavity based on the first pressure measurement, wherein the insufflation fluid is supplied according to a first setting which comprises at least a first volume and a first pressure. Supplying the insufflation fluid to the patient cavity includes directing the insufflation fluid through a first conduit to a bypass valve, the bypass valve including at least a first channel and a second channel defining a portion of a first flow path and first portion of a second flow path, respectively. Supplying the insufflation fluid to the patient cavity further includes directing the insufflation fluid to the patient cavity via the first flow path when the second channel is closed, wherein the first flow path is further defined by a second conduit coupling the first channel of the bypass valve to a first medical appliance, and directing the insufflation fluid to the patient cavity via the second flow path when the first channel is closed, wherein the second flow path is further defined by a second conduit coupling the second channel of the bypass valve to a second medical appliance
- According to yet another embodiment, a system includes an insufflator, a bypass valve, a first conduit, a second conduit, and a third conduit. The bypass valve includes at least a first channel and a second channel, the first channel defining a portion of a first flow path for the insufflation fluid and the second channel defining a portion of a second flow path for the insufflation fluid, wherein: the bypass valve is configured to permit the insufflation fluid to flow along the first flow path when the second channel is closed; and the bypass valve is configured to permit the insufflation fluid to flow along the second flow path when the first channel is closed. The first conduit is coupled to the bypass valve and configured to facilitate delivery of the insufflation fluid from the insufflator to the bypass valve. The second conduit is coupled to the first channel of the bypass valve and is configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a first medical appliance. The third conduit is coupled to the second channel of the bypass valve and is configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a second medical appliance.
- The teachings of the disclosure provide one or more technical advantages. Embodiments of the disclosure may have none, some, or all of these advantages. For example, in some embodiments, a method allows for the continuous monitoring of pressure associated with a patient cavity during and after insufflation of the patient cavity. Continuous monitoring may result in decreased potential for physician harm resulting from insufflation fluid leakage and thus may also result in an increase in physician confidence while performing surgical procedures. As another example, a method provides for intelligent pressure monitoring wherein pressure sensors are automatically disabled when not in use. Thus, the intelligent pressure monitoring feature is associated with a reduction in power and computing resources. As yet another example, a method provides for the elimination of duplicate insufflation components (e.g., insufflator and conduits connecting to insufflation delivery device such as an insufflation needle or trocar). Other advantages will be apparent to those of skill in the art.
- For a more complete understanding of embodiments of the disclosure and the potential advantages thereof, reference is now made to the following written description taken in conjunction with the accompanying drawings, in which:
-
FIG. 1 illustrates an example of an insufflation system comprising an insufflator, a trocar, an insufflation needle, and a valve, according to certain embodiments of the present invention; -
FIG. 2 illustrates the valve of the system ofFIG. 1 , according to certain embodiments of the present invention; -
FIG. 3 is a flow chart illustrating a method of insufflating a patient cavity using the valve ofFIG. 2 , according to one embodiment of the present invention; - and
-
FIG. 4 illustrates an example controller operable to control one or more components ofsystem 100, including the insufflator ofFIG. 1 . - One of the requirements for delivery of insufflation gas to a patient's body cavity is to maintain the proper flow of insufflation gas into the body cavity. Normally, gas flows from a high-pressure gas source, which is remote from the patient, through an insufflation device and finally into a trocar where the gas is injected into the patient's body cavity. Typically, the insufflation gas is stored in high-pressure containers and a pressure regulator reduces the pressure of the gas to a lower pressure. The low pressure gas is typically delivered to the trocar through an insufflation device containing a set of inline end connectors that couple the source of insufflation gas, the pressure regulator, the filter, the heater, the hydrator, and the trocar to each other. Typically, before being delivered to the patient cavity, the insufflation gas is conditioned by filtering, heating and/or hydrating. The insufflation gas may flow through any suitable number of inline end connectors, which are typically connected by flexible tubing (also referred to herein as conduits), before being delivered to the patient cavity.
- In some cases, physicians or other medical practitioners may prefer to deliver insufflation gas to patient cavity in two phases, first using a first medical appliance (e.g., an insufflation needle) and thereafter using second medical appliance (e.g., a trocar). Delivering insufflation gas via two different medical appliances may be preferred because one medical appliance may have a smaller profile than the other.
- Conventional two-phase insufflation may be associated with various drawbacks. As one example, one conventional solution requires two sets of insufflation components (e.g., insufflator, conduits); one set to be used with the first medical appliance and the other set to be used with the second medical appliance.
- Applicant has previously described and patented a solution that addresses and eliminates the need for insufflating using duplicative insufflation components. See U.S. Pat. No. 10,232,132 (“the '132 patent”) (incorporated by reference herein). The '132 patent generally describes a two-stage insufflation method using a trocar-adaptor-needle assembly (i.e., coupling, using an adaptor, a trocar cannula to an insufflation needle). At the first stage of the insufflation method, insufflation fluid is delivered through the trocar-adaptor-needle assembly; at the second stage of the insufflation method, insufflation fluid is delivered directly through the trocar cannula. Transition from the first stage of the insufflation method to the second stage of the insufflation method requires disconnection of the adaptor and needle from the trocar-adaptor-needle assembly. Although such adaptor eliminates the need for duplicative insufflation components, such delivery method is not a perfect solution. Notably, disconnection of the adaptor and needle from trocar-adaptor-needle assembly requires the removal of the trocar-adaptor-needle from the patient cavity. In the period of time that it takes to remove the trocar-adaptor-needle assembly, modify the trocar-adaptor-needle assembly, and thereafter position and insert the trocar in the patient cavity, leakage of the insufflation fluid may occur. Any leakage of the insufflation fluid results in deflation of the patient cavity and therefore diminishes the physician's view of the site of interest. As will be recognized by those of skill in the art, inserting a trocar into a patient cavity that is not sufficiently inflated is risky as the trocar may pierce or otherwise damage organs surrounding the site of interest.
- Other conventional two-phase insufflation solutions also experience the same leakage risk due to disconnection and reconnection of components. For example, a popular two-phase insufflation solution involves initially insufflating using a first medical appliance (e.g., an insufflation needle) connected to a conduit, that is in turn connected to the insufflator. Once the patient cavity is sufficiently insufflated using the first medical appliance, the conduit is disconnected from the first medical appliance and connected to a second medical appliance (e.g., a trocar). As one of ordinary skill in the art will recognize, disconnection and reconnection of the conduit to the first and second medical appliance, respectively, presents an opportunity for insufflation gas leakage and therefore also poses an increased risk of the medical procedure to the patient.
- The present disclosure describes an insufflation system and method that overcomes the shortcomings of the conventional insufflation solutions described above. In particular, the present disclosure describes an insufflation system and method that operates using a single set of insufflation components and reduces or eliminates leakage of insufflation gas during the insufflation process, in one embodiment. The insufflation system and method described herein also contemplates intelligent pressure monitoring which provides various efficiencies with respect to time and computing resources. Example embodiments are best understood by referring to
FIGS. 1 through 4 of the drawings and the description below, like numerals being used for like and corresponding parts of the various drawings. -
FIG. 1 is a schematic diagram of aninsufflation system 100. In some embodiments,insufflation system 100 includes aninsufflator 110, conduits 160, avalve 120, and one or more medical appliances. In the embodiment illustrated inFIG. 1 ,insufflation system 100 includes a first medical appliance (i.e., insufflation needle 130) and a second medical appliance (i.e., trocar 140). Other embodiments ofinsufflation system 100 may include other medical appliances. For example, in another embodiment, both the first and second medical appliances are trocars, the first medical appliance being a hasson trocar. As will be recognized by one of ordinary skill,system 100 may include one or more additional components. As an example,system 100 may further include a controller that controls the operation of one or more components ofFIG. 1 . This disclosure describes and depicts an example of such controller with respect toFIG. 4 . - Generally,
FIG. 1 shows the distal end ofinsufflation needle 130 andtrocar 140 positioned within theabdominal cavity 150 of a patient. In general,insufflator 110 supplies insufflation gas topatient cavity 150. The insufflation gas is directed from insufflator tovalve 120 viaconduit 160 a and is thereafter directed topatient cavity 150 via at least one flow path.FIG. 1 illustrates two flow paths: the first flow path, identified inFIG. 1 as “Flow Path A,” includesconduit 160 b andinsufflation needle 130; the second flow path, identified inFIG. 1 as “Flow Path B,” includesconduit 160 c andtrocar 140. As will be described in further detail below,valve 120 is configured to direct the insufflation gas to at least one of Flow Path A or Flow Path B. In addition to providing a flow path for insufflation gas,trocar 140 permits the insertion of a surgical instrument (not illustrated) intopatient cavity 150. In the embodiment illustrated inFIG. 1 , a physician or other medical practitioner can insert a surgical instrument through an innertubular lumen 146 oftrocar 140 in order to accesspatient cavity 150 with the surgical instrument. -
System 100 may further include one or more sensors 142. Sensors 142 are configured to measure a variable (e.g., pressure, humidity, temperature) and are, in some embodiments, communicatively coupled to other components of system 100 (e.g., controller ofsystem 100, insufflator 110). Sensors 142 may be communicatively coupled to components ofsystem 100 via a wired or wireless connection. As illustrated inFIG. 1 ,sensors insufflator 110 viacables system 100 may include instructing sensor 142 to take a measurement, sensor 142 reporting a measurement, instructinginsufflator 110 to supply insufflation gas under specified conditions (e.g., at a particular pressure and/or volume). - As illustrated in
FIG. 1 ,system 100 includes three sensors:sensors Sensor 142 a may be configured to (1) measure a humidity and/or temperature of the insufflation gas as it flows throughtrocar 140; and (2) communicate such measurement(s) toinsufflator 110 and/or a controller ofinsufflation system 100.Sensors patient cavity 150; and (2) communicate such measurement toinsufflator 110 and/or a controller ofinsufflation system 100. As will be described in further detail below,sensor 142 b may measure a pressure corresponding topatient cavity 150 through an outer tubular lumen 144 oftrocar 140 and sensor 14 b may measure a pressure corresponding topatient cavity 150 through Flow Path B. Although this disclosure describes and depicts only three sensors 142, this disclosure contemplatessystem 100 including any appropriate number of sensors. - Sensors 142 may sense pressure or a change in pressure. Sensor 142 may measure absolute pressure or a pressure relative to some other pressure. In some embodiments, sensor 142 is an absolute sensor that can measure pressure in patient cavity 150 (if disposed within patient cavity 150) or in the room in which the associated operation is taking place. In particular embodiments, sensor 142 can measure absolute barometric pressures with an accuracy of less than 1 Pascal pressure and therefore have the ability to measure the relative changes in altitude of close to one inch. Such pressure sensors are readily available in the marketplace.
Insufflator 110 ofsystem 100 may be any suitable source of insufflation gas at any suitable pressure and may include a pressurized gas source.Insufflator 110 may adjust the supply of insufflation gas topatient cavity 150 by adjusting the pressure and/or the volume of insufflation gas supplied topatient cavity 150. As described above,insufflator 110 may supply insufflation gas topatient cavity 150 based on one or more pressure measurements (e.g., pressure measurements taken bysensors 142 b and/or 142 c). The insufflation gas may be any suitable gas used for insufflation purposes. As one example, insufflation gas may be carbon dioxide. -
Insufflator 110 may include any appropriate hardware and/or software for processing signals indicative of insufflation gas measurements and processing such signals to convert them into useful information, such as converting them into pressures, heights, and/or other data that can be used control the flow of insufflation gas topatient cavity 150, and further for processing such data to determine a desired pressure and/or volume of insufflation gas supplied topatient cavity 150 and for effecting such delivery. Accordingly,insufflator 110 may include at least one processor, a computer-readable medium to store instructions, and at least one communication interface for receiving and sending information. In some embodiments,insufflator 110 includes a controller such as the controller 400 described and depicted inFIG. 4 . - As described above,
system 100 includesvalve 120.Valve 120 may be any suitable device configured to direct insufflation gas along two or more flow paths. As illustrated inFIGS. 1 & 2 ,valve 120 is configured to discharge insufflation gas to one of two flow paths: Flow Path A and Flow Path B. Insufflation gas carried via Flow Path A is discharged fromvalve 120 toconduit 160 b and is thereafter directed through a first medical appliance (e.g., insufflation needle 130) topatient cavity 150. In contrast, insufflation gas carried via Flow Path B is discharged fromvalve 120 toconduit 160 c and is thereafter directed through a second medical appliance (e.g., trocar 140) topatient cavity 150.Valve 120 is further described in reference toFIG. 2 . - As described above, conduits 160 may direct the flow of insufflation gas between components of
system 100. In some embodiments, conduits 160 couple to ports located on such components. For example, as illustrated inFIG. 1 ,conduit 160 a is coupled on one end to a port corresponding toinsufflator 110 and is coupled on the opposite end to a port corresponding tovalve 120. As another example,conduit 160 b is coupled on one end to a port corresponding tovalve 120 and is coupled on the opposite end to a port corresponding toinsufflation needle 130. As yet another example,conduit 160 c is coupled on one end to a port corresponding tovalve 120 and is coupled on the opposite end to a port corresponding to trocar 140. - Conduits 160 may comprise any suitable material that facilitates the transport of insufflation gas. As an example, conduits 160 may comprise flexible PVC tubing. In some embodiments, in addition to providing a pathway for transporting insufflation gas, conduits 160 provide a pathway for taking pressure measurements. As an example,
sensor 142 c may take a pressure measurement indicative of a pressure ofpatient cavity 150 viaconduits body cavity 150 may be taken via Flow Path A wheninsufflator 110 is not supplying insufflation gas. Althoughsystem 100 is described and depicted as having only three conduits 160, this disclosure contemplatessystem 100 including any suitable number ofconduits 140. - As described above,
system 100 includestrocar 140. Althoughsystem 100 is described and depicted as only having a single trocar (trocar 140), this disclosure contemplatessystem 100 including any suitable number oftrocars 140.Trocar 140 may be any suitable trocar through which insufflation gas may be supplied to a patient cavity. Examples of one or more trocars are provided in U.S. Pat. No. 8,715,219 (the '219 patent), U.S. Pat. No. 7,285,112 (the '112 patent), and U.S. Pat. No. 8,216,189 (the '189 patent), which are hereby incorporated by reference as if fully set forth herein.Trocar 140 may have a single lumen or may be formed with an inner tubular lumen and an outer tubular lumen such that insufflation gas may be supplied through one of the lumens but not the other. Further, any of the lumens may be divided into multiple, separate chambers, such that gas in one chamber does not enter the other chamber. Examples of the above multiple lumens and multiple chambered trocars are described in U.S. application Ser. No. 14/792,873, entitled “Method and System for Gas Maintenance to a Body Cavity Using a Trocar,” which is hereby incorporated by reference. Trocar may be open or closed at the distal end, as the application of the trocar would allow. - As illustrated in
FIG. 1 ,trocar 140 includes an outer tubular lumen 144 disposed about an innertubular lumen 146. Medical instruments (e.g., scope, grasper, scissors) may be inserted through innertubular lumen 146 oftrocar 140 in order to access the site of interest withinbody cavity 150. - In some embodiments, outer tubular lumen 144 is divided into two or more chambers (e.g.,
chamber 144 a andchamber 144 b). The division of outer tubular lumen 144 into separate chambers may provide benefits which will be recognized by one of ordinary skill in the art. As an example, by dividing outer tubular lumen 144 into two or more chambers,trocar 140 can deliver insufflation gas topatient cavity 150 while also measuring a pressure (e.g., using sensor 142) indicative of a pressure ofpatient cavity 150. As shown inFIG. 1 ,conduit 160 c directs insufflation gas tochamber 144 a oftrocar 140 where it is thereafter directed, viaapertures 148 a, topatient cavity 150. As is also shown inFIG. 1 ,apertures 148 b provide a path intochamber 144 b oftrocar 140 in whichsensor 142 b may take a pressure measurement indicative of a pressure ofpatient cavity 150. Althoughtrocar 140 is depicted inFIG. 1 as having twoapertures 148 a and twoaperture 148 b, this disclosure recognizes thattrocar 140 may include any suitable number ofapertures - As described above,
trocar 140 may include any suitable number of sensors 142, one or more of which may be capable of taking pressure measurements. Sensors 142 may be located anywhere in, on, or throughtrocar 140. In some embodiments, sensors 142 are located on the exterior oftrocar 140 such that changes of pressure within trocar 140 (e.g., due to the supply of insufflation gas to patient cavity 150) do not affect the pressure measured by sensor 142. As described above, sensors 142 may be absolute pressure sensors that can measure pressure in patient cavity 150 (if disposed within patient cavity 150) or in the room in which the associated operation is taking place. - Sensors 142 may be coupled to components of
system 100 through any suitable technique, including a wireless or a wired connection (e.g.,cables system 100, which may be comprised withininsufflator 110. In such an embodiment,insufflator 110 uses this pressure data to control the supply on insufflation gas byinsufflator 110. In particular embodiments, this may include determining the change in height oftrocar 140 relative to changes in cavity pressure and thus the resulting change in height ofpatient cavity 150, as described in greater detail in co-pending application Ser. No. 15/293,013 entitled Method and System for Controlling Pressurization of a Patient Cavity Using Cavity Distension Measured by a Pressure Sensor of a Trocar incorporated herein by reference. - Generally,
system 100 is used to insufflatepatient cavity 150. Upon coupling conduits 160 to components ofsystem 100 as illustrated inFIG. 1 , insufflation may begin. In some embodiments,insufflation needle 130 andtrocar 140 are inserted intopatient cavity 150 andvalve 120 is opened such that insufflation gas can be delivered via FlowPath A. Insufflator 110 may then be turned on such that insufflation gas is delivered topatient cavity 150 via Flow Path A. Before and/or during insufflation, one or more measurements are taken by sensors 142 and relayed toinsufflator 110 as described above. As is also described above,insufflator 110 supplies insufflation gas topatient cavity 150 based on measurements taken by sensors 142. Oncepatient cavity 150 has been insufflated to desired levels (e.g., 15 mmHg),valve 120 is adjusted to permit the flow of insufflation gas along Flow Path B such that insufflation gas is delivered topatient cavity 150 throughtrocar 140. - This disclosure recognizes that each component of
system 100 does not need to be coupled in order to begin insufflation. As an example, insufflation gas may be delivered along Flow Path A withoutfirst coupling conduit 160 c totrocar 140. To ensure efficiency benefits,conduit 160 c is coupled tovalve 120 andtrocar 140 beforevalve 120 is adjusted to permit insufflation fluid to flow along Flow Path B. In other words,system 100 may be assembled during or after use of one or more components ofsystem 100. - Furthermore,
system 100 may be disassembled during or after use of one or more components ofsystem 100. For example, upon insufflatingpatient cavity 150 withinsufflation needle 130 and adjustingvalve 120 to prevent insufflation gas from flowing along Flow Path A (or otherwise permit the flow of insufflation gas along Flow Path B),conduit 160 b andinsufflation needle 130 may be removed fromsystem 100. - This disclosure describes
valve 120 in further detail with respect toFIG. 2 and describes certain methods of insufflating a patient cavity with respect toFIG. 3 . Finally, this disclosure describes details of a controller ofsystem 100 with respect toFIG. 4 . -
FIG. 2 illustrates one embodiment ofvalve 120. As shown inFIG. 2 ,valve 120 is a ball valve that provides multiple flow paths. Although this disclosure describes and depictsvalve 120 as a ball valve, this disclosure recognizes thatvalve 120 may be any suitable type ofvalve 120 that provides multiple flow paths for insufflation gas. For the avoidance of doubt, this disclosure recognizesvalve 120 being any suitable solenoid or pneumatic valve. - As illustrated in
FIG. 2 ,valve 120 includeshandle 210,inlet 220, afirst outlet 230, asecond outlet 240, and aball 260. Generally,ball 260 is rotated withinvalve 120 based on movements ofhandle 210. One or more channels 250 withinvalve 120 may be opened asball 260 rotates withinvalve 120. As one example, turninghandle 210 90° may openchannel 250 a andclose channel 250 b. As a result of turninghandle 210 90°, insufflation gas may be permitted to flow intoinlet 220 and out ofvalve 120 viaoutlet 230. As another example, turninghandle 210 180° may openchannel 250 b andclose channel 250 a. As a result of turninghandle 210 180°, insufflation gas may be permitted to flow intoinlet 220 and out ofvalve 120 viaoutlet 240. As yet another example, turninghandle 210 270° may close two or more channels 250 (e.g., 250 a and 250 b) such that insufflation gas cannot flow along Flow Path A or Flow Path B (or insufflation gas is otherwise blocked from flowing intoinlet 220 of valve 120). In some embodiments, turninghandle 210 360° may open two or more channels 250 (e.g., 250 a and 250 b) such that insufflation gas is permitted to flow along Flow Path A and Flow Path B. Although this disclosure describes various settings forvalve 120, this disclosure contemplatesvalve 120 including any desirable valve setting that permits insufflation gas to flow (or not flow) through one or more components ofsystem 100. - In some embodiments,
conduit 160 a is coupled toinlet 220 to permit the flow of insufflation gas frominsufflator 110 tovalve 120. In some embodiments,conduit 160 b is coupled tooutlet 230 to permit the flow of insufflation gas along Flow Path A andconduit 160 c is coupled tooutlet 240 to permit the flow of insufflation gas along Flow Path B. Accordingly, this disclosure recognizes that turninghandle 210 may permit insufflation gas to flow along Flow Path A and/or Flow Path B. - In some embodiments,
valve 120 does not include handle 210 to control actuation ofball 260. Instead, ball 260 (or other suitable valve mechanism for blocking, or otherwise closing, channels 250) may actuate based on receipt of instructions from a controller (e.g., controller 400 ofFIG. 4 ). As described above, controller may be comprised withininsufflator 110. In other embodiments, such controller may be external toinsufflator 110. In some embodiments, controller is programmed to actuate ball 260 (or other suitable valve mechanism for blocking, or otherwise closing, channels 250) in a manner that closes one flow path (e.g., Flow Path A) and opens another flow path (e.g., Flow Path B) in response to determining that desired levels of insufflation gas have been attained (e.g., whenpatient cavity 150 has been insufflated to 15 mmHg). In this manner, insufflation gas may be continuously delivered topatient cavity 150 even though the flow path for the insufflation gas has changed. As will be recognized by one or ordinary skill, continuous flow of insufflation gas may result in certain benefits relative to conventional insufflation system, including reducing or eliminating leakage of insufflation gas. -
FIG. 3 is a flow chart illustrating amethod 300 of insufflating a patientcavity using system 100. The method may utilize structural items such as those described inFIGS. 1 through 2 or may use alternative structural items. Computational steps described below may be performed by any suitable computation device, including a controller that may or may not be a subcomponent ofinsufflator 110. - The
method 300 begins atstep 305 and continues to step 310. Atstep 310,system 100 measures a pressure indicative of a pressure ofpatient cavity 150. In some embodiments, the pressure measurement taken atstep 310 is measured by one or more sensors 142. As described above, sensors 142 may be located in, on, or throughtrocar 140 and/orinsufflator 110. In some embodiments, sensors 142 may continuously measure a pressure withinpatient cavity 150 and communicate a signal indicative of the measurement(s) to the controller ofsystem 100. - In some embodiments, one or more pressure measurements are taken by
sensor 142 b and communicated to a controller (e.g., controller 400 ofFIG. 4 . In such embodiment, gas may enter intoouter chamber 144 b oftrocar 140 throughapertures 148 b so that the pressure of the gas may be measured bysensor 142 b. In other embodiments, one or more pressure measurements are taken bysensor 142 c collocated withinsufflator 110. As will be recognized by those of ordinary skill, to ensure the accuracy of the reading, pressuremeasurements using sensor 142 c should occur wheninsufflator 110 is not supplying insufflation gas topatient cavity 150. Although this disclosure describes and depicts particular positions insystem 100 for sensors 142, this disclosure recognizes that sensors 142 may be located in any suitable position that would permit sensors 142 to measure pressure indicative of a pressure ofpatient cavity 150. Oncesystem 100 determines such pressure measurement(s), themethod 300 may proceed to step 320. - At
step 320,system 100 supplies insufflation gas topatient cavity 150 based on the pressure measurement taken atstep 310. As an example, if controller receives a pressure measurement atstep 310 of 15 mmHg, controller may instructinsufflator 110 to supply 1 L/min of insufflation gas to patient cavity. This disclosure recognizes that variables other than the pressure of insufflation gas may also be monitored and adjusted while delivering insufflationgas using system 100. As an example,sensor 142 a may be configured to sense humidity and/or temperature information which is relayed to a controller that thereafter instructsinsufflator 110 to adjust the humidity and/or temperature of the supply of insufflation gas. Once insufflation gas has been supplied topatient cavity 150, themethod 300 may proceed to decision step 350. - At
decision step 330,system 100 determines whetherfirst channel 250 a is open (not blocked) or closed (blocked). If at step 350,system 100 determines thatfirst channel 250 a is open, themethod 300 proceeds to astep 340 a. If at step 250,system 100 instead determines thatfirst channel 250 a is closed, themethod 300 proceeds to astep 340 b. - At
step 340 a,system 100 directs the insufflation gas to a first flow path (e.g., Flow Path A ofFIG. 1 ). Atstep 340 b,system 100 directs the insufflation gas to a second flow path (e.g., Flow Path B ofFIG. 1 ). As discussed above, it may be preferable to initially deliver insufflation gas via a first flow path and thereafter deliver insufflation gas via a second flow path. As described above, channels 250 ofvalve 120 may be opened or closed manually (e.g., by turning handle 210) and/or based on instructions provided by the controller of system 100 (e.g., controller 400). To deliver insufflation gas initially throughinsufflation needle 130 ofsystem 100,channel 250 a should be opened andchannel 250 b should be closed. Once channels are positioned as desired,insufflator 110 may discharge insufflation gas tovalve 120 viaconduit 160 a and can thereafter be directed toinsufflation needle 130 viaconduit 160 b (Flow Path A). In some embodiments, themethod 300 proceeds to anend step 345 once insufflation gas has been directed to either the first or second flow path. - Modifications, additions, or omissions may be made to the methods described herein without departing from the scope of the disclosure. The methods may include more, fewer, or other steps. Additionally, steps may be performed in any suitable order. As an example alternative method, the
method 300 may continue to a step whereby it is determined thatpatient cavity 150 is insufflated to a desired level (15 mmHg). Upon determining that the desired level has been reached, channel 250 a may be closed andchannel 250 b may be opened such that insufflation gas can be delivered along Flow Path B (rather than Flow Path A). In some embodiments, this transition may be performed automatically. For example, upon determining that patient cavity has a pressure of 15 mmHg, controller may instruct ball 260 (or other suitable valve mechanism for blocking, or otherwise closing, channels 250) to rotate such thatchannel 250 a is closed andchannel 250 b is open. - Additionally,
system 100 may also be configured to implement certain functionalities in response to determining that one or more channels 250 ofvalve 120 are closed. As an example,system 100 may automatically adjust the operational settings ofinsufflator 110 in response to determining that one channel 250 has been opened and another channel 250 has been closed. In such example, insufflator may receive instructions to adjust the volume and/or pressure of the insufflation gas being supplied in order to ensure that the pressure ofpatient cavity 150 is maintained in response to a controller ofsystem 100 determining thatchannel 250 a is closed. As another example,system 100 may automatically disable one or more sensors 142 from taking measurements (e.g., pressure measurements) in response to determining that one channel 250 has been opened and another channel 250 has been closed. As yet another example, in response to determining that two or more channels 250 are closed (e.g., based on pressure measurements indicative of the pressure of patient cavity 150),insufflator 110 may display, oninsufflator 110, a message indicating such (e.g.,insufflator 110 may display “OCCLUSION” or “ERROR”) In some embodiments, adjusting operational settings of system components (e.g., sensors 142, insufflator 110) may result in efficiency and/or timing benefits. - In some embodiments, controller of
system 100 determines that one or more channels 250 are closed based on a rapid pressure rate rise/decline. For example, controller may determine thatchannel 250 a and/or 250 b is closed by determining that the pressure withinpatient cavity 150 increased or decreased by 5 mmHG within 1 seconds. Although this disclosure identifies particular ways of identifying whether channel 250 is open or closed, this disclosure recognizes that identifying whether channel 250 is open or closed may be determined in any suitable way. -
Method 300 may also include one or more of the following steps: (1) determine that a first sensor 142 is providing inaccurate or unreliable pressure readings; and (2) to instructinsufflator 110 to supply insufflation gas based on measurements determined by a second sensor 142. In some embodiments, controller ofsystem 100 is responsible for performing these steps. In some embodiments, controller ofsystem 100 analyzes pressure measurement(s) received from a first sensor 142 for indications of whether the signals are indicative of the measured pressure being inaccurate or otherwise suggesting that first sensor 142 is operating in a less than optimal manner. Any suitable factors may be considered in such analysis; however, certain factors that may indicate first sensor 142 is operating in a less than optimal manner include (1) whether the received signal is not within an expected range for the received signal; (2) whether error data is received, such as whether errors have occurred due to interference from a power signal, the wrong number of bits have been received, data is received in the wrong format, or data is received with improper spacing (3) whether proper acknowledgment bits are not received from the primary pressure sensor, (4) whether the received signal is not within an expected voltage range, (5) whether expected new updated status bits are not received, such as whether a signal has changed enough to indicate a new measurement has occurred as opposed to a signal being so close to a previous signal to indicate no new measurement has occurred; and (6) in the case wheresystem 100 includes two or more pressure sensors 142, whether measurements by the two or more sensors 142 are not within a certain range of each other. Upon determining that first sensor 142 is providing inaccurate or unreliable pressure readings, controller ofsystem 100 may instructinsufflator 110 to supply insufflation gas based on pressure readings from a second sensor 142. In some embodiments, first sensor 142 is disabled upon determining that first sensor 142 is providing inaccurate or unreliable pressure readings. In other embodiments, pressure readings from first sensor 142 are ignored upon determining that first sensor 142 is providing inaccurate or unreliable pressure readings. - The
method 300 may also include one or more disassembly steps wherein components may be removed from system 100 (e.g.,insufflation needle 130 and/orconduit 160 b) although insufflation gas continues to be delivered to patient cavity 150 (e.g., viaconduit 160 c and trocar 140). - Although this disclosure describes and depicts particular embodiments of the present invention, it will be understood that various substitutions and alterations can be made therein without departing from the spirit and scope of the present invention, as defined by the following claims. For example, although sensors 142 have been described above as being located on
trocar 140 and/orinsufflator 110, sensor 142 may also be located on, in, or through other medical appliances as well. Such medical appliances may be or include one of: a needle, a stapler, a grasper, a pair of scissors, a scalpel, a cutter, an electrode, an end seal, a probe, a multiple access port, and a single access port. Although this disclosure identifies certain types of medical appliances (including trocars 140), this disclosure recognizes that sensor 142 may be located on, in, or through any suitable medical appliance. For example, this disclosure recognizes any medical appliance that can puncture the skin as a medical appliance. -
FIG. 4 illustrates an example controller 400 ofsystem 100, according to certain embodiments of the present invention. As described above, controller may be internal or external to one or more components ofsystem 100. In a particular embodiment, controller is comprised withininsufflator 110. Controller 400 may comprise one ormore interfaces 410,memory 420, and one ormore processors 430.Interface 410 receives input (e.g., sensor data, user input), sends output (e.g., instructions), processes the input and/or output, and/or performs other suitable operation.Interface 410 may comprise hardware and/or software. -
Processor 430 may include any suitable combination of hardware and software implemented in one or more modules to execute instructions and manipulate data to perform some or all of the described functions of controller 400. In some embodiments,processor 430 may include, for example, one or more computers, one or more central processing units (CPUs), one or more microprocessors, one or more applications, one or more application specific integrated circuits (ASICs), one or more field programmable gate arrays (FPGAs), and/or other logic. - Memory (or memory unit) 420 stores information.
Memory 420 may comprise one or more non-transitory, tangible, computer-readable, and/or computer-executable storage media. Examples ofmemory 420 include computer memory (for example, Random Access Memory (RAM) or Read Only Memory (ROM)), mass storage media (for example, a hard disk), removable storage media (for example, a Compact Disk (CD) or a Digital Video Disk (DVD)), database and/or network storage (for example, a server), and/or other computer-readable medium. - Modifications, additions, or omissions may be made to the systems, apparatuses, and methods described herein without departing from the scope of the disclosure. The components of the systems and apparatuses may be integrated or separated. Moreover, the operations of the systems and apparatuses may be performed by more, fewer, or other components. One skilled in the art will also understand that the system contemplated by this disclosure can include other components that are not illustrated but are typically included with such systems. Additionally, operations of the systems and apparatuses may be performed using any suitable logic comprising software, hardware, and/or other logic. As used in this document, “each” refers to each member of a set or each member of a subset of a set.
- Although this disclosure has been described in terms of certain embodiments, alterations and permutations of the embodiments will be apparent to those skilled in the art. Accordingly, the above description of the embodiments does not constrain this disclosure. Other changes, substitutions, and alterations are possible without departing from the spirit and scope of this disclosure.
Claims (20)
1. A method for insufflating a body cavity with insufflation fluid, the method comprising:
determining, by a controller, a first pressure measurement indicative of a pressure of a patient cavity;
supplying, by an insufflator, the insufflation fluid to the patient cavity based on the first pressure measurement, wherein the insufflation fluid is supplied according to a first setting, the first setting comprising at least a first volume and a first pressure and wherein supplying the insufflation fluid includes directing the insufflation fluid through a first conduit to a bypass valve, the bypass valve comprising at least a first channel and a second channel defining a portion of a first flow path and first portion of a second flow path, respectively; directing the insufflation fluid to the patient cavity via the first flow path when the second channel is closed, wherein the first flow path is further defined by a second conduit coupling the first channel of the bypass valve to a first medical appliance; and
directing the insufflation fluid to the patient cavity via the second flow path when the first channel is closed, wherein the second flow path is further defined by a third conduit coupling the second channel of the bypass valve to a second medical appliance.
2. The method of claim 1 , further comprising:
determining, by a pressure sensor of the first appliance, the first pressure measurement.
3. The method of claim 1 , further comprising:
receiving, via one or more cables coupling the first appliance to the insufflator, the first pressure measurement determined by the pressure sensor of the first appliance.
4. The method of claim 1 , further comprising:
in response to determining that the insufflation fluid is not being supplied to the patient cavity, instructing a pressure sensor of the insufflator to take the first pressure measurement, wherein the first pressure measurement is based on information delivered via the second flow path.
5. The method of claim 1 , further comprising:
subsequent to supplying insufflation fluid based on the first pressure measurement, supplying the insufflation fluid based on a second pressure measurement determined by a pressure sensor of the first appliance.
6. The method of claim 1 , further comprising:
determining, by the controller, that one of the first channel or the second channel is closed.
7. The method of claim 6 , further comprising:
in response to determining that one of the first channel or the second channel is closed, subsequently supplying, by the insufflator, the insufflation fluid according to a second setting, wherein:
the second setting comprises at least a first volume and a first pressure; and
the second setting is different than the first setting.
8. The method of claim 6 , further comprising:
instructing the pressure sensor of the insufflator to take a third pressure measurement in response to determining that the first channel is closed.
9. The method of claim 1 , further comprising:
instructing, by a controller, the valve to close one of the first channel or the second channel in response to determining that the pressure of the patient cavity is at or above a threshold.
10. A system comprising:
a bypass valve comprising at least a first channel and a second channel, the first channel defining a portion of a first flow path for insufflation fluid and the second channel defining a first portion of a second flow path for the insufflation fluid, wherein:
the bypass valve is configured to permit the flow of the insufflation fluid along the first flow path when the second channel is closed; and
the bypass valve is configured to permit the flow of the insufflation fluid along the second flow path when the first channel is closed;
a first conduit coupled to the bypass valve and is configured to facilitate delivery of the insufflation fluid from an insufflator to the bypass valve; and
a second conduit coupled to the first channel of the bypass valve and is configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a first medical appliance.
11. The system of claim 10 , wherein the first medical appliance is a trocar.
12. The system of claim 10 , further comprising a third conduit coupled to the second channel of the bypass valve and configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a second medical appliance.
13. A system comprising:
an insufflator;
a bypass valve comprising at least a first channel and a second channel, the first channel defining a portion of a first flow path for the insufflation fluid and the second channel defining a portion of a second flow path for the insufflation fluid, wherein:
the bypass valve is configured to permit the insufflation fluid to flow along the first flow path when the second channel is closed; and
the bypass valve is configured to permit the insufflation fluid to flow along the second flow path when the first channel is closed;
a first conduit coupled to the bypass valve and configured to facilitate delivery of the insufflation fluid from the insufflator to the bypass valve;
a second conduit coupled to the first channel of the bypass valve and configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a first medical appliance; and
a third conduit coupled to the second channel of the bypass valve and configured to facilitate delivery of the insufflation fluid from the bypass valve to the patient cavity via a second medical appliance.
14. The system of claim 13 , wherein:
the first medical appliance is a trocar; and
the trocar comprises a pressure sensor configured to determine a pressure measurement indicative of a pressure of the patient cavity.
15. The system of claim 13 , wherein the second medical appliance is one from the set comprising:
an insufflation needle; and
a hasson trocar.
16. The system of claim 13 , wherein the insufflator comprises a pressure sensor configured to determine, based on information delivered via the second flow path, a pressure measurement indicative of a pressure of the patient cavity.
17. The system of claim 13 , wherein the insufflator comprises:
a processor; and
a computer readable medium having logic stored thereon, the logic operable, when executed by the processor, to supply insufflation fluid to a patient cavity based on a pressure measurement.
18. The system of claim 14 , wherein the insufflator is configured to supply the insufflation fluid to the patient cavity based on the pressure measurement determined by the pressure sensor of the trocar in response to determining that the insufflation fluid is being delivered to the patient cavity along the first flow path.
19. The system of claim 16 , wherein insufflator is configured to supply the insufflation fluid to the patient cavity based on the pressure measurement determined by the pressure sensor of the insufflator in response to determining that the insufflation fluid is being delivered to the patient cavity along the second flow path.
20. The system of claim 17 , wherein the logic is further operable, when executed by the processor, to instruct a pressure sensor of the insufflator to take a pressure measurement in response to determining that insufflation fluid is not being supplied to the patient cavity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/148,590 US20230132683A1 (en) | 2019-05-09 | 2022-12-30 | Distributed flow path insufflation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/407,814 US11541191B2 (en) | 2019-05-09 | 2019-05-09 | Distributed flow path insufflation |
US18/148,590 US20230132683A1 (en) | 2019-05-09 | 2022-12-30 | Distributed flow path insufflation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/407,814 Division US11541191B2 (en) | 2019-05-09 | 2019-05-09 | Distributed flow path insufflation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230132683A1 true US20230132683A1 (en) | 2023-05-04 |
Family
ID=73046981
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/407,814 Active 2041-04-15 US11541191B2 (en) | 2019-05-09 | 2019-05-09 | Distributed flow path insufflation |
US18/148,590 Pending US20230132683A1 (en) | 2019-05-09 | 2022-12-30 | Distributed flow path insufflation |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/407,814 Active 2041-04-15 US11541191B2 (en) | 2019-05-09 | 2019-05-09 | Distributed flow path insufflation |
Country Status (1)
Country | Link |
---|---|
US (2) | US11541191B2 (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5251663A (en) * | 1992-08-14 | 1993-10-12 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | High-temperature, high-pressure oxygen metering valve |
US5443453A (en) * | 1994-04-21 | 1995-08-22 | Sherwood Medical Company | Stop-cock valve |
WO2004039415A2 (en) * | 2002-10-28 | 2004-05-13 | Northgate Technologies Inc. | Dual-capacity insufflator tube |
US20060169337A1 (en) * | 2005-02-01 | 2006-08-03 | Pentair Water Pool And Spa, Inc. | Valve with elbow joint diverter |
US8602058B1 (en) * | 2009-08-12 | 2013-12-10 | Gil Del Castillo | Pushbutton stopcock assembly |
US20140074015A1 (en) * | 2012-09-07 | 2014-03-13 | Surgiquest, Inc. | System having multiple pneumatically sealed trocars |
US20180073684A1 (en) * | 2015-03-24 | 2018-03-15 | Chiyoda Corporation | Gas pressure feed device |
US20180103977A1 (en) * | 2016-10-13 | 2018-04-19 | Lexion Medical, Llc | Method and System for Controlling Pressurization of a Patient Cavity Using Cavity Distension Measured by a Pressure Sensor of a Trocar |
US20180326200A1 (en) * | 2015-11-17 | 2018-11-15 | Hans-Juergen HOPF | Multi-way valve with multiple retention ring |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1807085A (en) * | 1928-07-25 | 1931-05-26 | Tridex Corp | Two-way valve |
FR2326734A1 (en) * | 1975-10-04 | 1977-04-29 | Wolf Gmbh Richard | GAS INSUFFLATION APPARATUS APPLICABLE IN PARTICULAR TO THE FILLING OF A BODY CAVITY |
US7854724B2 (en) * | 2003-04-08 | 2010-12-21 | Surgiquest, Inc. | Trocar assembly with pneumatic sealing |
US20060100579A1 (en) * | 2004-07-23 | 2006-05-11 | Usgi Medical Inc. | Apparatus and methods for controlling pressurization of a body cavity |
US10232132B2 (en) | 2012-12-20 | 2019-03-19 | Lexon Medical Llc | Cannula adapters |
US9404241B1 (en) * | 2013-08-29 | 2016-08-02 | Roland Joseph Davantes | Waste water diverter apparatus |
JP6979354B2 (en) * | 2014-08-15 | 2021-12-15 | ノースゲート テクノロジーズ インコーポレイテッドNorthgate Technologies Inc. | High resolution system and method for controlling high and low air flow rate |
CA2998709A1 (en) * | 2014-09-17 | 2016-03-24 | Canary Medical Inc. | Devices, systems and methods for using and monitoring medical devices |
US10595897B2 (en) * | 2016-08-30 | 2020-03-24 | Lexion Medical, Llc | Method and system for measuring pressure in a body cavity using a trocar |
WO2018039239A1 (en) * | 2016-08-22 | 2018-03-01 | Poll Wayne L | Continuous gas supply insufflator having exhaust line peritoneal pressure control methods |
-
2019
- 2019-05-09 US US16/407,814 patent/US11541191B2/en active Active
-
2022
- 2022-12-30 US US18/148,590 patent/US20230132683A1/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5251663A (en) * | 1992-08-14 | 1993-10-12 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | High-temperature, high-pressure oxygen metering valve |
US5443453A (en) * | 1994-04-21 | 1995-08-22 | Sherwood Medical Company | Stop-cock valve |
WO2004039415A2 (en) * | 2002-10-28 | 2004-05-13 | Northgate Technologies Inc. | Dual-capacity insufflator tube |
US20060169337A1 (en) * | 2005-02-01 | 2006-08-03 | Pentair Water Pool And Spa, Inc. | Valve with elbow joint diverter |
US8602058B1 (en) * | 2009-08-12 | 2013-12-10 | Gil Del Castillo | Pushbutton stopcock assembly |
US20140074015A1 (en) * | 2012-09-07 | 2014-03-13 | Surgiquest, Inc. | System having multiple pneumatically sealed trocars |
US20180073684A1 (en) * | 2015-03-24 | 2018-03-15 | Chiyoda Corporation | Gas pressure feed device |
US20180326200A1 (en) * | 2015-11-17 | 2018-11-15 | Hans-Juergen HOPF | Multi-way valve with multiple retention ring |
US20180103977A1 (en) * | 2016-10-13 | 2018-04-19 | Lexion Medical, Llc | Method and System for Controlling Pressurization of a Patient Cavity Using Cavity Distension Measured by a Pressure Sensor of a Trocar |
Also Published As
Publication number | Publication date |
---|---|
US20200353184A1 (en) | 2020-11-12 |
US11541191B2 (en) | 2023-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11033299B2 (en) | Multimodal surgical gas delivery system having continuous pressure monitoring of a continuous flow of gas to a body cavity | |
US11147935B2 (en) | Smoke evacuation system for continuously removing gas from a body cavity | |
US11229756B2 (en) | Multimodal surgical gas delivery system configured to maintain stable body cavity pressure when suction is used in the body cavity | |
US6299592B1 (en) | Laparoscopic insufflator | |
US11096718B2 (en) | Method and system for measuring pressure in a body cavity | |
US20240189524A1 (en) | Method and System for Delivering Insufflation Fluid | |
US8025640B2 (en) | Pressurized surgical valve | |
EP3409222B1 (en) | System for controlling pressurization of a patient cavity using a pressure sensor in a trocar | |
US20230132683A1 (en) | Distributed flow path insufflation | |
US20230226287A1 (en) | Method and system for measuring pressure in a body cavity | |
EP3659660B1 (en) | System for controlling pressurization of a patient cavity using a pressure sensor of a medical appliance | |
EP4027919A1 (en) | Method and system for measuring pressure in a body cavity | |
JP2551183Y2 (en) | Insufflation device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LEXION MEDICAL, LLC, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GEISZ, CARL M.;SMITH, DERREK W.;CUTA, CRAIG J.;REEL/FRAME:062244/0096 Effective date: 20190508 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |